atai Life Sciences (ATAI) announced key leadership appointments to advance its goal of delivering novel mental health therapeutics. Srinivas Rao M.D., Ph.D., has assumed the role of sole Chief Executive Officer, CEO, joined by the promotions of Kevin Craig, M.D., to Chief Medical Officer, CMO, Glenn Short, Ph.D., to Chief Scientific Officer, CSO, and the appointment of Gerd Kochendoerfer, Ph.D., as Chief Operating Officer, COO.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ATAI:
- Rising High: Innovative Industrial reports PharmaCann default
- Rising High: Exclusive talk with biopharma company HMNC Brain Health
- Rising High: Organigram acquires Motif Labs for C$90M upfront
- Rising High: Cannabis firms report quarterly earnings
- Rising High: Numinus Wellness to sell five Utah clinics for $3.53M